Department of Medicine, Imperial College London, Chelsea and Westminster Hospital, London, United Kingdom.
PLoS One. 2012;7(2):e29844. doi: 10.1371/journal.pone.0029844. Epub 2012 Feb 20.
Define and identify long-term non-progressors (LTNP) and HIV controllers (HIC), and estimate time until disease progression. LTNP are HIV-1(+) patients who maintain stable CD4(+) T-cell counts, with no history of opportunistic infection or antiretroviral therapy (ART). HIC are a subset of LTNP who additionally have undetectable viraemia. These individuals may provide insights for prophylactic and therapeutic development. Records of HIV-1(+) individuals attending Chelsea and Westminster Hospital (1988-2010), were analysed. LTNP were defined as: HIV-1(+) for >7 years; ART-naïve; no history of opportunistic infection and normal, stable CD4(+) T-cell counts. MIXED procedure in SAS using random intercept model identified long-term stable CD4(+) T-cell counts. Survival analysis estimated time since diagnosis until disease progression. Subjects exhibiting long-term stable CD4(+) T-cell counts with history below the normal range (<450 cells/µl blood) were compared to LTNP whose CD4(+) T-cell count always remained normal. Within these two groups subjects with HIV-1 RNA load below limit of detection (BLD) were identified. Of 14,227 patients, 1,204 were diagnosed HIV-1(+) over 7 years ago and were ART-naïve. Estimated time until disease progression for the 20% (239) whose CD4(+) T-cell counts remained within the normal range, was 6.2 years (IQR: 2.0 to 9.6); significantly longer than 4.0 years (IQR: 1.0 to 7.3) for patients with historical CD4(+) T-cell count below normal (Logrank chi-squared = 21.26; p<0.001). Within a subpopulation of 312 asymptomatic patients, 50 exhibited long-term stable CD4(+) T-cell counts. Of these, 13 were LTNP, one of whom met HIC criteria. Of the remaining 37 patients with long-term stable low CD4(+) T-cell counts, 3 controlled HIV-1 RNA load BLD. Individuals with stable, normal CD4(+) T-cell counts progressed less rapidly than those with low CD4(+) T-cell counts. Few LTNP and HIC identified in this and other studies, endorse the need for universal definitions to facilitate comparison.
定义并鉴定长期非进展者(LTNP)和 HIV 控制者(HIC),并估计疾病进展的时间。LTNP 是指 HIV-1(+)患者,其 CD4(+)T 细胞计数保持稳定,无机会性感染或抗逆转录病毒治疗(ART)史。HIC 是 LTNP 的一个亚组,其病毒血症也无法检测到。这些个体可能为预防性和治疗性发展提供见解。分析了在切尔西和威斯敏斯特医院(1988-2010 年)就诊的 HIV-1(+)个体的记录。LTNP 的定义为:HIV-1(+)超过 7 年;未经 ART 治疗;无机会性感染史,CD4(+)T 细胞计数正常且稳定。SAS 中的 MIXED 过程使用随机截距模型确定了长期稳定的 CD4(+)T 细胞计数。生存分析估计了从诊断到疾病进展的时间。将表现出长期稳定的 CD4(+)T 细胞计数且历史记录低于正常范围(<450 个细胞/µl 血液)的受试者与 LTNP 进行比较,后者的 CD4(+)T 细胞计数始终正常。在这两组中,确定了 HIV-1 RNA 载量低于检测限(BLD)的受试者。在 14227 名患者中,有 1204 名患者在 7 年前被诊断为 HIV-1(+)且未经 ART 治疗。其 CD4(+)T 细胞计数保持在正常范围内的 20%(239 名)的估计疾病进展时间为 6.2 年(IQR:2.0 至 9.6);显著长于历史 CD4(+)T 细胞计数低于正常的患者的 4.0 年(IQR:1.0 至 7.3)(对数秩卡方=21.26;p<0.001)。在 312 名无症状患者的亚群中,有 50 名表现出长期稳定的 CD4(+)T 细胞计数。其中,13 名是 LTNP,其中 1 名符合 HIC 标准。在其余 37 名长期稳定的低 CD4(+)T 细胞计数的患者中,有 3 名患者控制了 HIV-1 RNA 载量低于 BLD。具有稳定、正常 CD4(+)T 细胞计数的个体比具有低 CD4(+)T 细胞计数的个体进展更缓慢。在这项研究和其他研究中,很少有 LTNP 和 HIC 被鉴定出来,这支持了需要通用定义来促进比较的观点。